Afficher la notice abrégée

dc.creatorMouliou D.S., Dardiotis E.en
dc.date.accessioned2023-01-31T09:01:45Z
dc.date.available2023-01-31T09:01:45Z
dc.date.issued2022
dc.identifier10.3390/diagnostics12071555
dc.identifier.issn20754418
dc.identifier.urihttp://hdl.handle.net/11615/76781
dc.description.abstractThe novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their efficacy, as well as the diagnosis of some post-vaccination-reported adverse reactions. In this state-of-the-art review article, we present the current evidence regarding mainly the diagnosis of spontaneous allergic reactions, the skin occurrences, the vascular, blood, endocrine and heart events, the respiratory reports, the gastrointestinal, hepatic and kidney events, the reproductive and pregnancy issues and the muscle events, as well as the ear, eye, neurologic and psychiatric events following mRNA vaccination against COVID-19. We further present some evidence regarding the mRNA strategies and we discuss our expert opinion on the knowns and the unknowns towards the topic. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourceDiagnosticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85133405420&doi=10.3390%2fdiagnostics12071555&partnerID=40&md5=e2256cf1409280c9109423fcb4d20301
dc.subjectMDPIen
dc.titleCurrent Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknownsen
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée